NEW BLOG

Interchangeable Biosimilars: Plan and Patient Savings

Adoption of biosimilars has been slow. The release of an FDA-approved interchangeable biosimilar may provide an added boost in savings. Read more. 

Industry News

Published: September 29, 2022